Johnson & Johnson to pay $2 billion in settlement over antipsychotic drugs in nursing homes
By
Tim Mullaney
Nov 05, 2013
Pharmaceuticals giant Johnson & Johnson and some subsidiaries will pay more than $2.2 billion to settle claims that they inappropriately promoted antipsychotic drugs for use in nursing homes, the U.S....